Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
|Articles|March 1, 2001
An authorative voice on antenatal corticosteroids
The latest NIH consensus development panel has concluded that a single course of therapy can improve clinical outcomes for preterm infants. They also caution that more is not necessarily better.
Advertisement
Advertisement
Related to this article
Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.
Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
Placentas from older mothers held less NAD+, and in aged pregnant mice, nicotinamide riboside or the CD38 inhibitor 78c restored placental NAD+ and improved fetal growth.
Hugh Taylor, MD, outlines a stepwise approach to endometriosis therapy, from first-line oral contraceptives to oral GnRH antagonists for progestin-resistant patients.
Hosted by Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, the monthly series brings clinicians, researchers, innovators, advocates, and other voices across women’s health into conversations that rarely happen in the same room.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
2
Q&A: Anita Nelson, MD, on etonogestrel implant's 5-year approval and REMS certification
3
Menopause proteomic scores associated with cognitive aging, dementia risk
4
CD38 is tied to age-related placental NAD+ decline in preclinical study
5